The CRAFITY score: A promising prognostic predictor for patients with hepatocellular carcinoma treated with tyrosine kinase inhibitor and immunotherapy combinations

Yang, Y; Ouyang, JZ; Zhou, YZ; Zhou, JX; Zhao, H

Zhao, H (通讯作者),Chinese Acad Med Sci & Peking Union Med Coll, Dept Hepatobiliary Surg, Natl Canc Ctr, Canc Hosp,Natl Clin Res Ctr Canc, Beijing, Peoples R China.;Zhou, JX (通讯作者),Zhengzhou Univ, Dept Hepatobiliary & Pancreat Surg, Affiliated Canc Hosp, Zhengzhou, Henan, Peoples R China.

JOURNAL OF HEPATOLOGY, 2022; 77 (2): 574